Actemra 162 mg 4 vial @@ XXX

Store in Refrigerator @keyframes blinker { 50% { opacity: 0; } } Used for: Rheumatoid arthritis (RA) Systemic juvenile idiopathic arthritis (SJIA) Polyarticar juvenile idiopathic arthritis (PJIA) Giant cell arteritis (GCA) Cytokine release syndrome (CRS) associated with chimeric antigen receptor (CAR) T-cell therapy Systemic sclerosis-associated interstitial lung disease (SSc-ILD) Directions: Actemra is given as an intravenous (IV) infusion or a subcutaneous (SC) injection. The dosage and frequency of administration vary depending on the condition being treated. For RA, the recommended dosage is 4 mg/kg IV every 4 weeks, or 162 mg SC every other week or weekly. For SJIA and PJIA, the recommended dosage is 8 mg/kg IV every 4 weeks. For GCA, the recommended dosage is 8 mg/kg IV every 4 weeks for 6 months. For CRS, the recommended dosage is 8 mg/kg IV once. For SSc-ILD, the recommended dosage is 8 mg/kg IV every 4 weeks. Pack size: Actemra 400 mg/20 mL is aVialable as a single-use vial. Active ingredients: Tocilizumab Dosage: The dosage of Actemra varies depending on the condition being treated. See the "Directions" section for more information.